Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

EMFX unlikely to reverse 2024 losses over the next six months



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>RPT-POLL-EMFX unlikely to reverse 2024 losses over the next six months</title></head><body>

Repeats earlier story for wider readership with no change to text

By Vuyani Ndaba and Devayani Sathyan

JOHANNESBURG/BENGALURU, July 3 (Reuters) -Emerging market currencies will not reverse this year's losses against a resilient dollar in the next six months as China's economy struggles and the U.S. Federal Reserve holds back on interest rate cuts, according to a Reuters poll.

With the Fed not expected to cut rates as many times as financial markets had predicted at the beginning of the year, from around six then to just two now, that has left most emerging currencies vulnerable against a strong dollar.

Federal Reserve Chair Jerome Powell said on Tuesday that although the U.S. was back on a "disinflationary path" policymakers will need more data before they start cutting interest rates.

The dollar index .DXY is up 4.3% this year and was predicted to stay strong in the near term. EUR/POLL

Almost all emerging market currencies surveyed were forecast to not recoup the losses already made this year in the next three to six months, according to the June 28-July 3 survey of over 58 foreign exchange strategists.

China's troubled property sector is likely to weigh heavily on the economic and currency performance in the world's second-biggest economy, boding ill for the performance of other emerging market currencies. It remains the single biggest trading partner to many nations.

"We look for more depreciation of the yuan and Chinese growth is unlikely to pick up significantly in the months ahead, that also means less upside for the rest of Asia," said Mitul Kotecha, head of FX & EM macro strategy Asia at Barclays.

The tightly controlled Chinese yuan CNY= is expected to gain 0.3% by the end of 2024,after dropping 2.4% against the greenback so far this year.

"The overall outlook is still for more downside pressure in the next three to six months for EM currencies. Broadly the two main factors that will drive EM currencies continues to be dollar strength and relatively high U.S. rates," Kotecha added.

This is despite a small loss of around 1% in the emerging market currency index .MIEM00000CUS in which the yuan plays a big part.

China's economy was expected to drive EM currencies into gains at the start of this year when its economy opened wider after strict COVID-19 restrictions were relaxed.

Some major EM currencies such as the Indonesian rupiah IDR=, Korean won KRW=, Thai Bhat THB=, Singapore dollar SGD=, Taiwan dollar TWD= and Philippine peso PHP= were expected to gain between 1%-3% by the end of the year.

However, those gains would still be minuscule compared to the losses this year to date.

The Indian rupee INR=, which has stood out as the most stable among EM currencies, is set to trade within a narrow range over the year. INR/POLL

South Africa's rand ZAR=D3, is predicted to gain 2.8% in six months after a loss of about 1% in the first half.

The key to the rand outlook will be the U.S. interest rate cut timing, with markets still expecting with certainty the first cut in November, Annabel Bishop, chief economist at Investec wrote in a note.

Since national elections in late May when President Cyril Ramaphosa's African National Congress party lost its majority for the first time in three decades the rand has been very volatile.

The Russian rouble RUB= is expected to lose around 7.5% to 95.00 to the dollar while the Turkish lira TRY= will weaken nearly 10% to 36.09 to the dollar in the next six months.


(For other stories from the July Reuters foreign exchange poll: nL4N3IM0R6)



Reporting by Vuyani Ndaba and Devayani Sathyan; Polling by Veronica Khongwir, Susobhan Sarkar, Arun Purujit, Rahul Trivedi and Pranoy Krishna; Editing by Jonathan Cable and Christian Schmollinger

</body></html>

Mga Kaugnay na Asset


Pinakabagong Balita

Ozempic may gift US a $3 trln benefit


EUR/USD downward correction risk has increased

E

Romanian court reinstates influencer Andrew Tate's travel ban


Bernstein lifts JB Hunt's PT on intermodal volume upside

J

AngioDynamics Inc reports results for the quarter ended in May - Earnings Summary

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.